Atlas Trials

Refractory Cytopenia With Multilineage Dysplasia

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Cytopenia With Multilineage Dysplasia

RecordFirmDate
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02566304)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2015-11-13
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies (NCT01789255)National Cancer Institute (NCI)2013-06-01
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome (NCT00988715)Fred Hutchinson Cancer Center2010-04-21
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT (NCT01012492)Boston Children's Hospital2009-11-01
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome (NCT00589316)Fred Hutchinson Cancer Center2007-10-05
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia (NCT00462605)National Cancer Institute (NCI)2007-04-01
Vorinostat in Treating Patients With Acute Myeloid Leukemia (NCT00305773)National Cancer Institute (NCI)2006-01-01
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders (NCT00397813)Fred Hutchinson Cancer Center2006-01-01
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes (NCT00104962)National Cancer Institute (NCI)2005-03-01
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00119366)Fred Hutchinson Cancer Center2003-05-01
Tipifarnib in Treating Patients With Myelodysplastic Syndromes (NCT00005845)National Cancer Institute (NCI)2002-06-01
Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT00008177)Fred Hutchinson Cancer Center1999-07-27

Track Refractory Cytopenia With Multilineage Dysplasia automatically

Every clearance here is in the API, with alerts when new ones post.